 Cell Movement
"Cell Movement" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
| Descriptor ID |
D002465
|
| MeSH Number(s) |
G04.198 G07.568.500.180
|
| Concept/Terms |
Cell Movement- Cell Movement
- Cell Movements
- Movements, Cell
- Movement, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Movement".
Below are MeSH descriptors whose meaning is more specific than "Cell Movement".
This graph shows the total number of publications written about "Cell Movement" by people in this website by year, and whether "Cell Movement" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 3 | 5 | | 1997 | 1 | 3 | 4 | | 1998 | 4 | 5 | 9 | | 1999 | 0 | 5 | 5 | | 2000 | 2 | 6 | 8 | | 2001 | 5 | 15 | 20 | | 2002 | 2 | 15 | 17 | | 2003 | 4 | 13 | 17 | | 2004 | 7 | 11 | 18 | | 2005 | 7 | 16 | 23 | | 2006 | 8 | 9 | 17 | | 2007 | 9 | 8 | 17 | | 2008 | 5 | 18 | 23 | | 2009 | 11 | 27 | 38 | | 2010 | 7 | 16 | 23 | | 2011 | 13 | 25 | 38 | | 2012 | 14 | 21 | 35 | | 2013 | 9 | 34 | 43 | | 2014 | 14 | 25 | 39 | | 2015 | 10 | 30 | 40 | | 2016 | 15 | 24 | 39 | | 2017 | 13 | 28 | 41 | | 2018 | 14 | 29 | 43 | | 2019 | 1 | 22 | 23 | | 2020 | 7 | 18 | 25 | | 2021 | 3 | 12 | 15 | | 2022 | 1 | 10 | 11 | | 2023 | 0 | 10 | 10 | | 2024 | 4 | 5 | 9 | | 2025 | 6 | 12 | 18 | | 2026 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Movement" by people in Profiles.
-
Falta NA, Larsen LD, Gupta K, Can UI, Kian A, Pan JD, Evans CM, Reinhardt RL, Spencer LA. Gut-derived, inflammatory ILC2s disseminate type 2 immunity to remote lung in food allergen-challenged mice. J Leukoc Biol. 2026 May 13; 118(5).
-
Owens JM, Weppner HK, Ignes-Romeu A, Burleson JW, Hind LE. Interleukin-6 regulates the neutrophil response to diverse bacteria. Front Immunol. 2026; 17:1783843.
-
Baird MA, Jewett CE, Malide DA, Kratz L, Cartagena-Rivera AX, Fischer RS, Waterman CM. Lamin B receptor upregulation in metastatic melanoma causes nuclear envelope fragility in confined migration during cancer invasion. Proc Natl Acad Sci U S A. 2026 Feb 24; 123(8):e2513031123.
-
Perez Almeria CV, Otun O, Schlimgen R, Lamme TD, Di Niro L, Crudden C, Bebelman JP, Youssef N, Musli L, Jenjak S, Bobkov V, Drube J, Hoffmann C, Volkman BF, Granier S, Bechara C, Siderius M, Heukers R, Schafer CT, Smit MJ. Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies. Nat Commun. 2025 Dec 02; 16(1):10828.
-
Neumann A, Sampath R, Mayerhofer E, Mikalayeva V, Skeberdis VA, Sarapiniene I, Prekeris R. Ubiquitylation-dependent Rap2 activation regulates lamellipodia dynamics during cell migration. J Cell Sci. 2025 Dec 01; 138(23).
-
Weppner HK, Singh MA, Katsnelson EN, Douin DJ, McCarter MD, Tobin RP, Hind LE. Human M-MDSCs impair neutrophil migration in the infectious microenvironment. J Leukoc Biol. 2025 Dec 01; 117(12).
-
Geng D, Chen J, Sanchez A, Davalos SA, Wilcox P, Gonzales-Rivera D, Couts K, Tobin R, Robinson W, Nielsen AJ, Guo J, McCarter M, Crump L, Tsujimoto K, Wilky BA, Davila E. Melanoma leverages innate immune IRAK-M signaling to limit metastasis through PTPN22-Induced signaling repression. Cancer Lett. 2026 Feb 28; 639:218172.
-
Neumann A, Prekeris R. Checking in with EPLIN: EPLINa as a regulator of integrin trafficking. Dev Cell. 2025 Nov 17; 60(22):3000-3001.
-
Nakamura K, Di Caprio N, Taasan JT, Crosby CO, Burdick JA. Dynamic Regulation of Granular Hydrogels Through Guest-Host Interactions to Spatiotemporally Guide Cellular Migration. Adv Sci (Weinh). 2026 Jan; 13(5):e12971.
-
Subramanian C, McNamara K, Hess D, Croslow SW, Tan Y, Kiseljak-Vassiliades K, Wierman ME, Sweedler JV, Cohen MS. A novel therapeutic approach to adrenocortical carcinoma repurposing fingolimod to target sphingolipid metabolism in metastatic disease. Surgery. 2026 Jan; 189:109702.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|